- Home
- MIST vs ITRG Comparison
MIST vs ITRG Comparison
Compare MIST & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIST | ITRG |
|---|---|---|
| Founded | 2003 | 1997 |
| Country | Canada | Canada |
| Employees | N/A | 329 |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.9M | 557.9M |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | MIST | ITRG |
|---|---|---|
| Price | $0.76 | $2.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $8.00 | $5.13 |
| AVG Volume (30 Days) | 1.4M | ★ 1.8M |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,915.14 | $67.34 |
| Revenue Next Year | N/A | $25.89 |
| P/E Ratio | ★ N/A | $45.07 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.78 | $1.99 |
| 52 Week High | $3.06 | $4.87 |
Technical Indicators
Market Signals| Indicator | MIST | ITRG |
|---|---|---|
| Relative Strength Index (RSI) | 24.10 | 50.73 |
| Support Level | N/A | $2.62 |
| Resistance Level | $1.42 | $2.80 |
| Average True Range (ATR) | 0.07 | 0.11 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 4.99 | 48.92 |
Price Performance
Historical ComparisonAbout MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.